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Abstract
Defective glycosylphosphatidylinositol (GPI)-anchor biogenesis can cause a spectrum of predom-
inantly neurological problems. For eight genes critical to this biological process, disease associa-
tions are not yet reported. Scanning exomes from 7,833 parent–child trios and 1,792 singletons
from the DDD study for biallelic variants in this gene-set uncovered a rare PIGH variant in a boy
with epilepsy, microcephaly, and behavioral difficulties. Although only 2/2 reads harbored this
c.1A > T transversion, the presence of ∼25 Mb autozygosity at this locus implied homozygosity,
which was confirmed using Sanger sequencing. A similarly-affected sister was also homozygous.
FACS analysis of PIGH-deficient CHO cells indicated that cDNAs with c.1A > T could not effi-
ciently restore expression of GPI-APs. Truncation of PIGH protein was consistent with the utiliza-
tion of an in-frame start-site at codon 63. In summary, we describe siblings harboring a homozy-
gous c.1A>T variant resulting in defectiveGPI-anchor biogenesis and highlight the importance of
exploring low-coverage variants within autozygous regions.
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Rare genetic variants that result in defective glycosylphosphatidyli-
nositol (GPI)-anchor biogenesis have been linked to a phenotypic
spectrum of conditions that include learning disability, epilepsy,
microcephaly, mild dysmorphic features, and other congenital
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in anymedium, provided
the original work is properly cited.
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malformations (Johnstone et al., 2017; Makrythanasis et al., 2016; Ng
& Freeze, 2015). Although more than 20 genes have been implicated
to date, analysis of exome data from 4,293 trios showed that disease
causing variants in this pathway account for only around 0.15% of
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cases with developmental disorders (Pagnamenta et al., 2017). In this
study,we interrogated theOctober3, 2016data release fromtheDeci-
pheringDevelopmental Disorders (DDD) study (www.ddduk.org) com-
prising exomes for 7,833 parent–child trios and 1,792 singletons. We
specifically searched for biallelic variants in the remaining eight genes
critical to this pathway for which human disease associations are yet
to be reported: PIGB, PIGF, PIGH, PIGK, PIGS, PIGU, PIGX, andMPPE1.
Patients were recruited to the DDD study under UK Research
EthicsCommittee approval (10/H0305/83;Cambridge SouthREC, and
GEN/284/12; Republic of Ireland REC). In brief, reads weremapped to
hs37d5 and variants were called using a combination of GATK, SAM-
tools, and Dindel for SNV and indels, and in-house CoNVex for CNVs.
Candidate de novo variants were called in trio data with DeNovoGear.
More detailed methods have been described previously (Deciphering
Developmental Disorders, 2017;Wright et al., 2015).
The only variant in the restricted set of eight GPI-anchor biogene-
sis genes that passed all filter thresholds (<1%AF in all subpopulations
from gnomAD) and fits with the presumed autosomal-recessive inher-
itance pattern was an apparently homozygous c.1A > T; p.(Met1Leu)
transversion in PIGH (MIM# 600154; NM_004569.3; rs761543313).
This variantwas identified in aboy (DECIPHER ID265247but referred
to hereafter as IV-1) with short stature, epilepsy, developmental delay,
and behavioral difficulties. No other likely pathogenic variants have
been identified in this boy. The c.1A> T variantwas present in the gno-
mAD database (https://gnomad.broadinstitute.org) at an overall allele
frequency of 0.002% (4/172732 or 4/25236 in the South Asian sub-
group; all observations in the heterozygous state) but absent from the
1000Genome Project (phase3v5b).
Unfortunately, exome coverage was very low at the PIGH start
codon (2×, 3×, and 5× in the proband,mother, and father, respectively).
Decreasing coverage below 15× increases the chance of heterozygous
variants incorrectly being called homozygous, with very few heterozy-
gous genotypes being called at 2× (Supp. Figure 1). However, the fact
that both parents were heterozygous carriers of c.1A > T made the
homozygous call in IV-1 plausible. Review of high confidence SNVs on
chr14 indicated that the c.A > T variant lay within a ∼25 Mb region
of autozygosity between rs2275504 and rs10131300 (Supp. Figure 2).
Together with the documented consanguinity (Figure 1A), this pro-
vided further support that the variant was homozygous. Bidirectional
Sanger sequencing, performed using an ABI 3730XL instrument, later
confirmed homozygosity in IV-1 and his similarly affected sister (IV-
2), while both parents were heterozygous (Figure 1B). The variant was
also detected in an RNA sample obtained from the mother, suggest-
ing that the mutant transcript is not significantly degraded (Supp. Fig-
ure 3). In silico analysis shows the variant has a PHRED-scaled CADD
score of 27.6 and PolyPhen-2 ranks it as possibly damaging.
The proband (IV-1) was born at 40 weeks weighing 3.12 kg (18th
centile) to consanguineous Pakistani parents, following an uncompli-
cated pregnancy. His early developmentwas reported to be normal; he
walked at 14–15 months and had said his first words by 1 year of age.
He developed febrile convulsions aged 14 months, which progressed
to afebrile generalized myoclonic seizures at 3 years of age. These
responded well to sodium valproate treatment. This treatment was
stopped at the age of 12 years and he has remained seizure free until
18 years of age when he had one further seizure. Sodium valproate
was subsequently recommenced. He had an episode of osteomyelitis
of the left calcaneum at 6 years of age. He has chronic otitismediawith
effusion. He has mild learning difficulties and attended mainstream
school with support. He also had behavioral difficulties, and as a child,
he was described as being overfriendly and tactile with strangers. As a
teenager, he struggled tomake friends and could be aggressive.
On examination as a toddler, his height was on the 50th centile and
weight over the 90th centile. At 9 years of age, his occipitofrontal cir-
cumference (OFC) was between the 0.4 and 2nd centiles. His growth
ratedeceleratedduring childhood, andby theageof12years9months,
his height was 141.4 cm (7th centile), weight was 32 kg (6th centile),
and OFC was 51.1 cm (1st centile). Clinodactyly of the 5th fingers
(Figure 1C) and toes was noted. Neither parent has clinodactyly. He
had forward turned ear lobes and creases on the posterior aspect of
the helices. He had dry skin, which has been suspected to represent
ichthyosis. He also has a speckled lentiginous nevus on the right side
of his torso. A diagnosis of Smith-Magenis syndrome was considered,
but FISH for 17p11.2 was negative. Chromosome microarray analysis
and SCN1A sequencing were normal. AnMRI brain scan demonstrated
subtle, non-specific findings including small areas of abnormal signal in
both globus palladi (right more than left) and a dysplastic rostrum of
the corpus callosum (Figure 1D).
His younger sister (IV-2) was born after a normal pregnancy at
40weeks by normal vaginal delivery. She developed epilepsywith gen-
eralized tonic clonic seizures starting at 3.5 years of age, initially febrile
and then afebrile. The seizures have proved difficult to control and
surgical treatment has been discussed. Similar to her brother, her ini-
tial development was normal. She also initially attended mainstream
school with extra help, but was later moved to a special school. She has
difficulties with both verbal and nonverbal communication. She also
has behavioral difficultieswith temper tantrums and aggressive behav-
ior toward strangers. Skin pigmentation is normal. She has 5th toe clin-
dactyly, but no other dysmorphic features, pigmentary or skin abnor-
malities. Her growth parameters at the age of 7.5 years were: weight
of 19.7 kg (2–9th centile), height of 121 cm (25–50th centile). OFCwas
50.1 cm, putting her between the 0.4 and 2nd centiles, whereas 2 years
previously herOFChadbeenbetween the25and50th centiles. Similar
to her brother, herMRI brain scan has shown amildly dysplastic corpus
callosum (Figure1E) andnon-specific foci of abnormal high signal in the
deepwhitematter (Figure 1F). A recent PET scan has shown increased
uptake of glucose in the temporal regions. Neither parent has had sim-
ilar symptoms or signs.
Abnormal levels of alkaline phosphatase in blood serum are a
biomarker for some forms of GPI-anchor deficiency, particularly when
mutations involve PIGV, PIGO, PGAP2, or PGAP3 (HPMRS1-4). How-
ever, in this case, alkaline phosphatasewaswithin the normal range for
both siblings;most recentmeasurementswere 107 IU/L (normal range
40–240) for IV-1 and 228 IU/L (84–307) for IV-2. Triglyceride levels
were in the normal range for IV-1 (1.20 mM) but significantly raised
in IV-2 (3.20 mM; normal range 0.45–1.62). Raised triglyceride levels
have been associatedwith patients with PIGA deficiency and it is spec-
ulated that this is due to a secondary deficiency of GPIHBP1 (Tarailo-
Graovac et al., 2015).
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F IGURE 1 Pedigree, Sanger sequence data, and clinical images. A: Simplified pedigree for patient 265247, which shows parents to be first-
cousins.B: Genomic DNAwas PCR amplified using FastStart Taq polymerase (Roche), with GC-rich additive and primers CAGAGGGTGAAGAGTC-
CGTAandGGAAGAACGCACAACCATCA. Sanger sequencingof exoSAPpurifiedPCRproducts, performedusingBigDyev3.1 chemistry, confirmed
that the c.1A> T variant was homozygous in both the proband and his affected sister (red arrows), while their parents were heterozygous carriers.
The sequences shown are from the+ve strand primer but inverted to show the coding direction alongside the corresponding wild-type amino acid
sequence. The canonical methionine start codon is highlighted in green. C: Photograph of proband's hands demonstrating clinodactyly.D: Saggital
T1 weightedMRI image of IV-1 at 8 years of age demonstrating a dysplastic corpus callosumwith a slightly truncated and rounded appearance of
the rostrum of the corpus callosum. Axial T2 FLAIR image demonstrating abnormal signal within the globus pallidi bilaterally but more prominent
on the right.E: T1weightedMRI scan for IV-2 showing a very slightly dysplastic corpus callosum, againwith a truncated appearance of the rostrum.
F: Axial T2 weighted MRI scan images for IV-2 showing nonspecific increased high signal foci in the deep white matter bilaterally, most notably in
the parietal regions
One method commonly used to functionally assess variants in
genes associated with the GPI-anchor biogenesis is to perform FACS
analysis on patient granulocytes. CD16 is often used as it is thought to
be the most sensitive marker (Kato et al., 2014; Tanigawa et al., 2017).
However, CD16 levels are also affected by how blood samples are
handled and so patient samples are often compared to a small number
of unrelated controls processed in the same batch. Such studies can
potentially be confounded by the fact that granulocyte CD16 levels
are variable among healthy individuals. In this study, FACS analysis
demonstrated that IV-1, IV-2, and III-2 all had median CD16 levels in
between with the values obtained for two unrelated control subjects
(Supp. Figure 4). To minimize the effects of genetic background and/or
environmental factors, the functional consequences of the c.1A > T
variant was assessed using plasmids containing wild-type or mutant
PIGH cDNA, whichwere transfected by electroporation (400 𝜇l, 250 V,
950𝜇F,GenePulser II; Bio-Rad, Tokyo, Japan) intoPIGH-deficientCHO
cells. Co-transfection with a luciferase-expressing plasmidwas used to
monitor transfection efficiency. Two days after transfection, restora-
tion of GPI-AP was analyzed by FACS. Although no difference was
observed when using a strong SR alpha promoter (pME), when expres-
sion was driven by a weaker TK promoter (pTK), mutant PIGH could
not efficiently restore the surface expression of GPI-APs (Figure 2A).
Western blot analysis of protein expression using the pME construct
demonstrated that the variant results in a truncated version of PIGH,
consistent with utilization of an alternate in-frame start site in exon 2
at the next available methionine codon at position 63 (Figure 2B).
PIGH encodes a relatively small endoplasmic reticulum-associated
protein of 188 amino acids. Together with five other subunits,
PIGH is an essential component of phosphatidylinositol (PI) N-
acetylglucosaminyltransferase, an enzyme that is critical for the first
step in GPI-anchor biosynthesis. The enzyme catalyzes the transfer
of N-acetylglucosamine (GlcNAc) from uridine 5′-diphospho N-acetyl
glucosamine (UDP-GlcNAc) to PI to form GlcNac-PI (EC 2.4.1.198).
Studies on the orthologous gene in yeast suggest the PIGH subunit is
critical for biological activity (Yan,Westfall, & Orlean, 2001). Although
truncationof amino acids 1–62 (the likely effect of the c.1A>Tvariant)
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F IGURE 2 FACS andWestern blot analysis using CHO cells.A: PIGH-knockout CHO cells were generated and transfectedwith humanwild-type
or c.1A> Tmutant PIGH cDNA cloned into pME or pTK expression vectors. Restoration of the cell surface expression of CD59, DAF, and uPARwas
evaluated by flow cytometry. Anti-CD59 (5H8), DAF (IA10), and uPAR (5D6) were made in house. The mutant construct using the pTK promoter
did not rescue surface expression of CD59 or uPAR as efficiently as the wild-type construct, indicating that the variant results in reduced PIGH
activity.B: Levels of expressedwild-type and c.1A> Tmutant HA-tagged PIGH in pME-vector transfected cells were analyzed byWestern blotting
using an anti-HA antibody (C29F4 Rabbit mAb; Cell Signaling; 1:15,000). After normalization with luciferase activity and GAPDH (Anti-GAPDH,
AM4300 mouse mAb Ambion; 1:2,000), expression of full-length PIGH (*) was reduced almost to zero and instead there was a smaller band (**),
which likely represents a truncated version of PIGH in which translation starts from an alternativeMet63 codon in exon 2. Although a larger band
can be detected at around 30 kDa (***), it is unclear where this starts because there are no in-framemethionine codons upstream
represents a loss of 33% of the wild-type PIGH protein, our results
suggest that some residual activity is retained (Figure 2A). However,
studies have shown that in certain situations, initiation from UUG
codons can occur (Kearse & Wilusz, 2017) and so it is also possible a
trace amount of full-size PIGH, likely generated using Leu1 (Figure 2B),
contributed to the residual activity.
Although a PIGH splicing variant in Belgian Blue cattle has been
shown to result in arthrogryposis (Sartelet et al., 2015), the conse-
quences of PIGH mutations in humans have not yet been described.
In contrast, phenotypes associated with germline variants in the five
genes encoding the other essential components of this complex have
already been elucidated. Germline mutations in PIGA were originally
reported to cause a X-linked lethal disorder involving cleft palate,
neonatal seizures, contractures, central nervous system structural
malformations, and other anomalies (Johnston et al., 2012). Milder
cases have since been described where the manifestation include pro-
found learning disability, axial hypotonia, epilepsy, and hypsarrhyth-
mia (Belet et al., 2014) or neurodegenerative encephalopathywith sys-
temic iron overload and ichthyosiform skin lesions (Swoboda et al.,
2014). A homozygous splice variant in PIGQ has been linked to Ohta-
hara syndrome (Martin et al., 2014) whilst a p.(R207*) alteration has
been linked to intractable seizures, developmental delay, and optic
atrophy (Alazami et al., 2015). A missense variant in PIGY resulted in
a multi-system disease involving dysmorphism, epilepsy, severe devel-
opmental delay, cataracts, and early death, while a regulatory variant
was associated with a milder presentation limited to moderate devel-
opment delay and microcephaly (Ilkovski et al., 2015). Mutations in
PIGC are associated with epilepsy and intellectual disability (Edvard-
son et al., 2017), while those in PIGP have been linked to infantile
epileptic encephalopathy (Johnstone et al., 2017). To sum up, although
epilepsy is a common finding, many other variable features can co-
occur.We speculate that the relativelymild phenotype observed in the
siblings described here is due to some residual activity and that bial-
lelic PIGHmutations that result in zero activity would lead to a signifi-
cantly more severe presentation. Further studies and the recruitment
of additional patients with PIGH variants would be required to test this
hypothesis.
GC content is well known to influence the resulting read coverage
obtained by exome capture methodologies (Clark et al., 2011). Due to
the presence of CpG islands at the 5′ ends of many genes, genetic vari-
ants in or around the start-codon are therefore less likely to be called
robustly than in other gene regions (Supp. Figure 5). In this case, we
identified a homozygous c.1A > T with only 2× coverage. In a previ-
ous study, we identified a homozygous c.-540G>A variant in the PIGY
promoter, with only 4× coverage (Ilkovski et al., 2015). Variants with
these levels of coverage are often considered low-confidence and fil-
tered out at early stages of analysis. Even if retained, low coverage
variants are less likely to be genotyped accurately in terms of distin-
guishing heterozygosity from homozygosity (Supp. Figure 1). Together,
these studies highlight the value of scrutinizing low coverage variants
involving transcriptional or translational start sites, especially when
they lie within regions of autozygosity. Our systematic analysis iden-
tified two siblings from the DDD study with homozygous disruption
of the PIGH start codon, which leads to the use of an alternative start
site and defective GPI-anchor biogenesis resulting in a developmental
disorder characterized by developmental delay, seizures, and micro-
cephaly. Further cases are required to confirm the phenotypic range
associated with rare biallelic PIGH variants.
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